Current Issue

In dieser Ausgabe:

The Endocannabinoid System in PTSD: Molecular Targets for Modulating Fear and Anxiety

Fear and anxiety perform essential protective roles, yet when they become dysregulated, they can trap trauma survivors in persistent hypervigilance and distress. Post-traumatic stress disorder (PTSD) manifests as intrusive memories, avoidance, and heightened arousal long after the precipitating event. Although current pharmacotherapies – including selective serotonin reuptake inhibitors, adrenergic blockers, benzodiazepines, and atypical antipsychotics – provide relief for some, many patients co...

weiterlesen ...

Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease

Serotonergic psychedelics, such as lysergic acid diethylamide, and psilocybin, and the entactogen 3,4-methylenedioxymethamphetamine exhibit agonist activity at the 5-hydroxytryptamine 2B receptor, a signalling pathway known to mechanistically mediate drug-induced valvular heart disease. This systematic review evaluates whether chronic or repeated use of psychedelics and 3,4-methylenedioxymethamphetamine may contribute to valvular heart disease through sustained 5-hydroxytryptamine 2B receptor ac...

weiterlesen ...

The Effect of Kidney Function and Cardiovascular and Anti-Inflammatory Comedications on the Serum Concentration of Risperidone under Naturalistic Conditions

Polypharmacy has an important role in psychiatry, as the kidney function can be affected by medication. Risperidone is metabolized hepatically to 9-hydroxyrisperidone and excreted renally. Here, we study how serum concentrations of risperidone, 9-hydroxyrisperidone and active moiety (risperidone+9-hydroxyrisperidone) are related to impairment of kidney function and potentially interacting comedications that affect renal functions ((1) nonsteroidal anti-inflammatory drugs, (2) angiotensin-convert...

weiterlesen ...

Can Red Blood Cell Membrane Fatty Acids Predict Intracellular Lithium Concentration in Bipolar Disorder? A Cross-Sectional Study

Bipolar disorder is a chronic psychiatric condition that requires long-term treatment. Lithium remains the gold standard for mood stabilization; yet, its therapeutic response is highly variable and unpredictable due to the lack of reliable biomarkers. As lithium may exert its effect through interactions with neuronal membranes, particularly their lipid composition, red blood cell membranes have been proposed as a peripheral model to investigate this relationship. We conducted a monocentric, cros...

weiterlesen ...

DOI: 10.1055/s-016-63089

Pharmacopsychiatry

Ausgabe 02 · March 2026

Original Paper

Review

74
Xu, Tianyi; Wong, Sabrina; Le, Gia Han; Dri, Christine E.; Teopiz, Kayla M.; Lu, Andy; Lee, Serene; Rhee, Taeho Greg; Yin, Liyang; Bargiota, Stavroula; Ho, Roger; McIntyre, Roger S. : Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease

Original Paper

88
Heng, Monika; Diot, Thomas; Millet, Bruno; Ferreri, Florian; Duflot, Akhila; Adrien, Vladimir : Can Red Blood Cell Membrane Fatty Acids Predict Intracellular Lithium Concentration in Bipolar Disorder? A Cross-Sectional Study
Bitte klicken Sie hier, wenn Sie nicht automatisch weitergeleitet werden.

Contact

Contact us directly at pharmaco@thieme.de

Production Editor Contact us directly

Customer service Tel:+49-711-8931-321 Fax:+49-711-8931-422 aboservice@thieme.de

Cookie-Einstellungen